HRS Aluglaze IPO vs Streebo Solutions IPO

Comparison between HRS Aluglaze IPO and Streebo Solutions IPO.

IPO Details

HRS Aluglaze IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Streebo Solutions IPO is a SME Bookbuilding proposed to list at NSE SME.

Issue Size and Price

The total issue size of HRS Aluglaze IPO is up to ₹48.28 Cr whereas the issue size of the Streebo Solutions IPO is up to ₹0.00 Cr. The final issue price of HRS Aluglaze IPO is ₹96.00 per share and of Streebo Solutions IPO is .

 HRS Aluglaze IPOStreebo Solutions IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹94.00 per share
Issue Price (Upper)₹96.00 per share
Issue Price (Final)₹96.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size1200 shares
Fresh Issue Size50,29,200 shares17,08,000 shares
Fresh Issue Size (Amount)up to ₹48.28 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total50,29,200 shares17,08,000 shares
Issue Size Total (Amount)up to ₹48.28 Crup to ₹0.00 Cr

IPO Timetable

HRS Aluglaze IPO opens on Dec 11, 2025, while Streebo Solutions IPO opens on . The closing date of HRS Aluglaze IPO and Streebo Solutions IPO is Dec 15, 2025, and , respectively.

Financials & KPIs

HRS Aluglaze IPO P/E ratio is 26.07, as compared to Streebo Solutions IPO P/E ratio of .

 HRS Aluglaze IPOStreebo Solutions IPO
Financials

Company Financials (Restated Consolidated)

HRS Aluglaze Ltd.'s revenue increased by 56% and profit after tax (PAT) rose by 188% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets91.1680.6042.4334.10
Total Income26.3542.1426.9722.69
Profit After Tax4.545.151.790.87
EBITDA8.4510.703.531.75
NET Worth24.6120.119.968.17
Reserves and Surplus10.6613.453.461.67
Total Borrowing41.0438.6624.3517.91
Amount in ₹ Crore

Company Financials (Restated Standalone)

Streebo Solutions Ltd.'s revenue increased by 26% and profit after tax (PAT) rose by 1343% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets15.098.148.26
Total Income21.5717.1416.75
Profit After Tax5.290.371.02
EBITDA7.160.821.29
NET Worth12.937.647.28
Reserves and Surplus7.937.637.27
Total Borrowing0.010.01
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)10099.99
Promoter Shareholding (Post-Issue)72.49
P/E Ratio26.07
Market Cap₹185.11 Cr.
ROE34.2451.40
ROCE15.9754.70
Debt/Equity1.92
EPS₹3.68
RoNW34.2440.89

Shares Offered

In the HRS Aluglaze IPO Retail Individual Investors (RII) are offered 17,85,600 shares while in Streebo Solutions IPO retail investors are offered 17,85,600 shares. Qualified Institutional Buyers (QIB) are offered 14,43,600 shares in HRS Aluglaze IPO and 0 shares in Streebo Solutions IPO.

 HRS Aluglaze IPOStreebo Solutions IPO
Anchor Investor Reservation10,44,000 shares0 shares
Market Maker Reservation2,74,800 shares92,000 shares
QIB14,43,600 shares0 shares
NII7,56,000 shares0 shares
RII17,85,600 shares0 shares
Employee0 shares0 shares
Others
Total50,29,200 shares0 shares

Bids Received (Subscription)

HRS Aluglaze IPO subscribed 44.83x in total, whereas Streebo Solutions IPO subscribed .

Compare with others

Compare: